MADISON HEIGHTS, MI / ACCESSWIRE / Apr 16, 2014 / Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX), CEN Biotech announced today that it has engaged Push Point Management Group (PPMG), to provide strategic corporate consulting and capital markets support to CEN Biotech’s management team. Under the scope of services, PPMG will implement a unique set of strategic initiatives that will be focused on generating shareholder value.
PPMG supports its clients and management teams with effective strategic solutions that include market analysis, corporate and capital market counsel, corporate governance, risk management, regulatory compliance, introduction to capital, strategic branding and product rollouts, with a focus on broadening shareholder base, providing better visibility and creating liquidity for its companies.
"This is a major initiative for our Company,” stated Bill Chaaban, President & CEO, “We identified an effective corporate advisory team that has an expertise in generating results for shareholders from its corporate clients, including Fortune 500 companies. This engagement comes at an opportune time as we have recently announced several key initiatives that support our focus and pursuit for innovation and leadership in the medical IP space, including technology, manufacturing, pharmaceutical and supplement verticals. With more attention on the health industry, it is important that we are working with a highly respected and diversified team such as PPMG to provide more oversight as we continue to make further progress in our space.”
About PPMGPush Point Management Group (PPMG) and its subsidiary Push Point Media Group are comprised of a coalition of seasoned business veterans with extensive experience in both the private and public business sectors. PPMG provides clients and partners with innovative, expert project teams and full service offerings that create meaningful experiences and powerful business solutions.
About CEN BiotechCEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada. http://www.cenbiotechinc.com/
About Creative Edge Nutrition, Inc. Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.cenergynutrition.com/ and https://www.facebook.com/CenergyNutrition
About RXNB, Inc. RXNB possesses proprietary, cutting-edge systems in the field of agriculture, applicable to medical marijuana. In particular, these technologies focus on Current Good Manufacturing Practices (cGMP) manufacturing and growing process of medicinal marijuana. cGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities, which assures the identity, strength, quality, and purity of drug products. RXNB technologies will accelerate plant growth, allow perpetual grow cycles of about 35 days and protect plants from adulterants, which will yield greater harvests. RXNB has a pharmacy division, which dispenses prescription drugs direct to approximately 50,000 patients per month in the US. RXNB owns a distribution network, which supplies approximately 2,700 clinicians with tailored functional medicine across the US. It operates its own call center and owns software technologies in the field of tailored specialty drugs and batch record keeping in compliance with USP 797.
Contact:INVESTOR RELATIONSWilliam Swalm (212) 584-4342 [email protected]
Source: Creative Edge Nutrition, Inc.